Monoclonal antibody to SARS-CoV-2 Nucleocapsid protein, clone 21F9
R1-148-100
Datasheet as| Name | Monoclonal antibody to SARS-CoV-2 Nucleocapsid protein, clone 21F9 | |
| Immunogen | Nucleocapsid protein SARS-CoV-2 | |
| Immunogen Description | Recombinant SARS-CoV-2 Nucleocapsid protein produced by CHO-based Icosagen Cell factory Ltd. proprietary suspension cell line | |
| Clonality | Recombinant human monoclonal | |
| Clone | 21F9 | |
| Class | human IgG1-lambda | |
| Reactivity | SARS-CoV-2 Nucleocapsid protein | |
| Dissociation constant (KD) | 3.42 x 10-10 M
|
|
| Application | ELISA, WB | |
| Protocol | ELISA: 0.63 - 1.25 µg/ml WB: 0.5 – 1 µg/ml |
|
| Purification | Protein A affinity chromatography following desalting | |
| Buffer | PBS pH 7.4 | |
| Unit Size | 100 µg |
|
| Shipping | Shipped on dry ice | |
| Storage |
|
|
| Limitations | This product is for research use only. |
Buy now
€300 / 100µg
€500 / 500µg
€745 / 1000µg
custom quantity - ask quotation